A discussion of the ethical issues raised by a patient’s request for off-label, prophylactic bariatric surgery to prevent diabetes mellitus type 2 (DM type 2).
Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?
Amidst discussions of how to maximize physician contributions in high-risk disaster situations, the author asks if doctors are actually duty-bound to contribute at all.